Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free OABIW Stock Alerts

OmniAb (OABIW) Financials

OmniAb logo
$0.09 +0.01 (+11.25%)
As of 03:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for OmniAb

Annual Income Statements for OmniAb

This table shows OmniAb's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -27 -22 -51 -62 -65
Consolidated Net Income / (Loss)		 -27 -22 -51 -62 -65
Net Income / (Loss) Continuing Operations		 -27 -22 -51 -62 -65
Total Pre-Tax Income 		-34 -26 -64 -71 -66
Total Operating Income		 -36 -27 -69 -75 -69
Total Gross Profit		 35 59 34 26 18
Total Revenue		 35 59 34 26 19
Operating Revenue		 35 59 34 26 19
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.30
Operating Cost of Revenue		 - - - 0.00 0.30
Total Operating Expenses		 70 86 104 101 87
Selling, General & Admin Expense		 17 25 33 31 29
Research & Development Expense		 39 48 57 55 48
Amortization Expense		 13 13 14 17 13
Other Operating Expenses / (Income)		 1.21 -0.59 0.19 -2.37 -2.55
Total Other Income / (Expense), net		 1.26 0.59 5.06 3.09 2.68
Interest & Investment Income		 0.00 0.59 5.06 3.11 2.66
Other Income / (Expense), net		 1.27 0.00 0.00 -0.02 0.02
Income Tax Expense		 -7.31 -3.73 -14 -9.38 -1.52
Basic Earnings per Share		 ($0.33) ($0.26) ($0.51) ($0.61) ($0.57)
Weighted Average Basic Shares Outstanding		 82.61M 85.32M 99.68M 102.37M 113.64M
Diluted Earnings per Share		 ($0.33) ($0.26) ($0.51) ($0.61) ($0.57)
Weighted Average Diluted Shares Outstanding		 82.61M 85.32M 99.68M 102.37M 113.64M
Weighted Average Basic & Diluted Shares Outstanding		 - 115.58M 117.13M 122.13M 144.78M

Quarterly Income Statements for OmniAb

This table shows OmniAb's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -16 -14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71
Consolidated Net Income / (Loss)		 -16 -14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71
Net Income / (Loss) Continuing Operations		 -16 -14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71
Total Pre-Tax Income 		-19 -20 -22 -16 -19 -15 -18 -16 -18 -15 -7.27
Total Operating Income		 -20 -21 -23 -16 -20 -16 -19 -16 -18 -16 -7.83
Total Gross Profit		 5.48 4.82 3.80 7.61 4.17 11 4.15 3.64 2.21 8.36 14
Total Revenue		 5.48 4.82 3.80 7.61 4.17 11 4.15 3.90 2.24 8.38 14
Operating Revenue		 5.48 4.82 3.80 7.61 4.17 11 4.15 3.90 2.24 8.38 14
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.26 0.03 0.01 0.02
Operating Cost of Revenue		 - - - 0.00 0.00 - 0.00 0.26 0.03 - 0.02
Total Operating Expenses		 26 26 26 24 24 27 23 20 20 24 22
Selling, General & Admin Expense		 8.51 7.87 8.34 7.97 7.08 7.36 7.92 7.68 6.78 6.84 6.62
Research & Development Expense		 14 15 15 14 13 13 13 11 10 14 9.64
Amortization Expense		 3.40 3.41 3.41 4.54 3.39 6.06 3.23 3.23 3.23 3.23 6.03
Other Operating Expenses / (Income)		 0.02 -0.01 0.05 -2.52 0.15 -0.04 -0.75 -1.92 -0.03 0.15 -0.05
Total Other Income / (Expense), net		 1.27 1.18 0.98 0.78 0.68 0.66 0.54 0.46 0.45 1.22 0.56
Interest & Investment Income		 1.27 1.18 0.98 0.79 0.69 0.66 0.54 0.44 0.46 1.23 0.49
Other Income / (Expense), net		 0.01 - 0.00 -0.01 -0.01 - 0.00 0.03 -0.01 -0.01 0.08
Income Tax Expense		 -3.30 -5.98 -2.62 -1.90 -2.71 -2.16 -0.11 0.12 -1.16 -0.37 0.44
Basic Earnings per Share		 ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06)
Weighted Average Basic Shares Outstanding		 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M
Diluted Earnings per Share		 ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06)
Weighted Average Diluted Shares Outstanding		 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M
Weighted Average Basic & Diluted Shares Outstanding		 116.24M 117.13M 117.62M 118.16M 121.01M 122.13M 122.34M 122.70M 143.96M 144.78M 144.97M

Annual Cash Flow Statements for OmniAb

This table details how cash moves in and out of OmniAb's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.00 34 -17 11 -2.07
Net Cash From Operating Activities		 -5.67 -3.59 2.35 -40 -36
Net Cash From Continuing Operating Activities		 -5.67 -3.59 2.35 -40 -36
Net Income / (Loss) Continuing Operations		 -27 -22 -51 -62 -65
Consolidated Net Income / (Loss)		 -27 -22 -51 -62 -65
Depreciation Expense		 16 18 19 24 22
Amortization Expense		 - -0.17 -3.44 -1.50 -0.86
Non-Cash Adjustments To Reconcile Net Income		 14 19 25 22 14
Changes in Operating Assets and Liabilities, net		 -8.75 -18 12 -22 -6.16
Net Cash From Investing Activities		 -4.03 -73 -18 38 6.47
Net Cash From Continuing Investing Activities		 -4.03 -73 -18 38 6.47
Purchase of Property, Plant & Equipment		 -4.07 -17 -1.64 -1.88 -0.57
Purchase of Investments		 0.00 -55 -113 -40 -47
Divestitures		 - - - 0.00 3.00
Sale and/or Maturity of Investments		 1.27 0.07 100 80 51
Other Investing Activities, net		 -1.22 -1.44 -4.44 -0.40 0.00
Net Cash From Financing Activities		 9.70 111 -0.89 13 28
Net Cash From Continuing Financing Activities		 9.70 111 -0.89 13 28
Issuance of Common Equity		 0.00 97 1.21 15 29
Other Financing Activities, net		 9.70 14 -2.10 -1.61 -0.77

Quarterly Cash Flow Statements for OmniAb

This table details how cash moves in and out of OmniAb's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 0.26 -4.89 2.70 1.73 6.44 0.36 -17 7.39 10 -3.01 3.52
Net Cash From Operating Activities		 -6.20 -9.12 -17 -12 -6.58 -3.87 -16 -5.15 -9.76 -5.67 -4.91
Net Cash From Continuing Operating Activities		 -6.20 -9.12 -17 -12 -6.58 -3.87 -16 -5.15 -9.76 -5.67 -4.91
Net Income / (Loss) Continuing Operations		 -16 -14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71
Consolidated Net Income / (Loss)		 -16 -14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71
Depreciation Expense		 4.84 4.93 4.95 6.10 4.93 7.61 0.97 4.65 4.66 7.71 0.61
Amortization Expense		 -0.83 -0.79 -0.62 -0.38 -0.29 -0.21 3.54 -0.20 -0.17 -0.24 6.41
Non-Cash Adjustments To Reconcile Net Income		 5.86 5.94 5.68 5.93 5.30 5.14 4.17 1.21 4.00 4.21 3.40
Changes in Operating Assets and Liabilities, net		 -0.34 -5.15 -8.08 -10 -0.14 -3.33 -6.34 5.07 -1.72 -3.17 -7.62
Net Cash From Investing Activities		 6.29 4.73 20 13 4.45 0.39 -0.88 12 -7.67 2.71 8.44
Net Cash From Continuing Investing Activities		 6.29 4.73 20 13 4.45 0.39 -0.88 12 -7.67 2.71 8.44
Purchase of Property, Plant & Equipment		 -0.49 -0.11 -0.93 -0.75 -0.15 -0.05 -0.21 -0.17 -0.18 -0.01 -0.17
Purchase of Investments		 -31 -26 -5.42 -11 -8.98 -15 -10 -8.34 -20 -8.28 -9.40
Sale and/or Maturity of Investments		 38 31 27 25 14 15 9.59 18 13 11 18
Net Cash From Financing Activities		 0.17 -0.50 -0.20 0.80 8.57 3.85 0.04 0.24 28 -0.05 0.00
Net Cash From Continuing Financing Activities		 0.17 -0.50 -0.20 0.80 8.57 3.85 0.04 0.24 28 -0.05 0.00
Issuance of Common Equity		 0.19 0.22 1.00 1.14 8.59 3.90 0.04 0.30 28 0.15 0.00

Annual Balance Sheets for OmniAb

This table presents OmniAb's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 304 421 375 326 301
Total Current Assets		 23 125 95 68 65
Cash & Equivalents		 0.00 33 16 28 26
Short-Term Investments		 0.00 55 71 32 29
Accounts Receivable		 21 30 3.84 5.27 7.39
Prepaid Expenses		 1.41 6.40 4.07 3.43 3.93
Plant, Property, & Equipment, net		 6.80 20 18 15 9.43
Total Noncurrent Assets		 275 276 262 242 226
Goodwill		 84 84 84 84 84
Intangible Assets		 176 167 155 138 125
Other Noncurrent Operating Assets		 15 25 23 20 17
Total Liabilities & Shareholders' Equity		 304 421 375 326 301
Total Liabilities		 70 80 61 38 34
Total Current Liabilities		 21 26 23 15 16
Short-Term Debt		 2.54 4.02 1.30 0.53 1.04
Accounts Payable		 2.92 2.97 4.41 2.30 1.88
Accrued Expenses		 3.75 5.56 7.07 6.14 6.29
Current Deferred Revenue		 11 8.21 6.85 2.34 3.16
Other Current Liabilities		 0.58 1.78 3.49 3.78 3.88
Total Noncurrent Liabilities		 50 54 38 23 18
Capital Lease Obligations		 13 24 22 19 16
Noncurrent Deferred Revenue		 9.23 4.33 0.86 0.12 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 22 21 11 2.31 0.79
Other Noncurrent Operating Liabilities		 5.12 4.14 3.23 1.04 0.39
Total Equity & Noncontrolling Interests		 234 341 315 288 267
Total Preferred & Common Equity		 234 341 315 288 267
Preferred Stock		 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 234 341 315 288 267
Common Stock		 0.00 330 354 389 433
Retained Earnings		 0.00 11 -39 -101 -166
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.01 0.05 0.03 0.01

Quarterly Balance Sheets for OmniAb

This table presents OmniAb's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 238 413 405 392 353 337 332 306 296 310 294
Total Current Assets		 0.42 121 116 107 77 67 67 54 48 66 65
Cash & Equivalents		 0.02 23 21 21 19 21 27 11 18 29 29
Short-Term Investments		 - 91 82 75 50 36 32 33 23 31 20
Accounts Receivable		 - 1.82 8.61 6.14 4.05 6.88 3.50 6.48 2.71 3.10 13
Prepaid Expenses		 0.40 5.66 4.18 4.08 3.67 3.20 3.73 3.51 3.30 3.75 3.41
Plant, Property, & Equipment, net		 0.00 19 19 19 18 17 16 15 14 13 9.02
Total Noncurrent Assets		 237 273 270 266 258 253 249 238 234 230 220
Goodwill		 - 84 84 84 84 84 84 84 84 84 84
Intangible Assets		 - 164 162 159 152 148 144 135 132 128 119
Other Noncurrent Operating Assets		 237 24 24 24 22 21 21 19 18 18 16
Total Liabilities & Shareholders' Equity		 238 413 405 392 353 337 332 306 296 310 294
Total Liabilities		 14 72 71 67 51 43 40 33 34 32 31
Total Current Liabilities		 10 22 24 25 18 14 14 11 13 13 14
Short-Term Debt		 - 2.47 2.81 1.75 0.89 0.33 0.51 0.35 1.12 0.72 1.00
Accounts Payable		 6.39 2.49 2.36 2.50 3.56 2.81 2.19 1.93 1.98 1.91 1.65
Accrued Expenses		 1.53 3.91 4.93 6.52 4.03 4.55 5.45 3.58 4.71 5.15 4.03
Current Deferred Revenue		 - 6.89 7.27 7.38 5.53 2.91 2.51 1.73 0.98 1.64 2.94
Other Current Liabilities		 2.35 2.44 3.42 3.45 3.52 3.56 3.75 3.81 3.84 3.86 3.94
Total Noncurrent Liabilities		 4.03 51 47 42 34 29 25 21 21 19 17
Capital Lease Obligations		 - 23 23 23 21 21 20 19 18 17 16
Noncurrent Deferred Revenue		 - 3.02 3.48 1.95 0.28 0.07 0.04 0.00 0.04 0.00 0.37
Noncurrent Deferred & Payable Income Tax Liabilities		 - 20 17 14 8.74 6.84 4.13 2.21 2.33 1.17 1.23
Other Noncurrent Operating Liabilities		 4.03 3.73 3.42 3.56 3.21 1.24 1.16 0.39 0.66 0.60 0.11
Total Equity & Noncontrolling Interests		 -14 341 334 325 301 294 292 274 262 277 263
Total Preferred & Common Equity		 -14 341 334 325 301 294 292 274 262 277 263
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -14 341 334 325 301 294 292 274 262 277 263
Common Stock		 0.00 336 343 350 360 366 380 393 398 429 437
Retained Earnings		 -14 5.15 -9.58 -25 -58 -72 -88 -120 -135 -152 -174
Accumulated Other Comprehensive Income / (Loss)		 - 0.01 -0.05 -0.05 -0.02 -0.03 0.05 0.01 -0.00 0.01 -0.00

Annual Metrics And Ratios for OmniAb

This table displays calculated financial ratios and metrics derived from OmniAb's official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - 143,955,400.00
DEI Adjusted Shares Outstanding		 - - - - 143,955,400.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - -0.45
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 70.02% -42.17% -22.75% -29.27%
EBITDA Growth		 0.00% 52.63% -522.73% 1.74% 8.34%
EBIT Growth		 0.00% 22.41% -160.50% -7.35% 7.47%
NOPAT Growth		 0.00% 25.17% -160.50% -7.32% 7.43%
Net Income Growth		 0.00% 17.41% -126.65% -22.55% -4.43%
EPS Growth		 0.00% 21.21% -96.15% -19.61% 6.56%
Operating Cash Flow Growth		 0.00% 36.76% 165.43% -1,789.99% 8.09%
Free Cash Flow Firm Growth		 0.00% 0.00% 61.66% -161.01% 37.72%
Invested Capital Growth		 0.00% 12.23% -10.59% -1.15% -7.09%
Revenue Q/Q Growth		 0.00% 0.00% -47.19% 29.31% -11.51%
EBITDA Q/Q Growth		 0.00% 0.00% -136.10% 14.03% 0.37%
EBIT Q/Q Growth		 0.00% 0.00% -77.25% 6.65% 0.15%
NOPAT Q/Q Growth		 0.00% 0.00% -77.26% 6.67% 0.17%
Net Income Q/Q Growth		 0.00% 0.00% -70.17% 1.56% -1.75%
EPS Q/Q Growth		 0.00% 0.00% -82.14% 1.61% 3.39%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -45.73% 11.69% -5.20%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 12.69% 1.92%
Invested Capital Q/Q Growth		 0.00% 0.00% -0.56% -1.92% -2.28%
Profitability Metrics		 - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 98.38%
EBITDA Margin		 -52.06% -14.50% -156.19% -198.67% -257.46%
Operating Margin		 -102.48% -45.11% -203.19% -282.30% -369.49%
EBIT Margin		 -98.83% -45.11% -203.19% -282.36% -369.41%
Profit (Net Income) Margin		 -77.82% -37.80% -148.16% -235.05% -347.04%
Tax Burden Percent		 78.72% 85.70% 78.65% 86.87% 97.71%
Interest Burden Percent		 100.02% 97.80% 92.72% 95.83% 96.14%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -9.97% -7.03% -18.28% -20.90% -20.17%
ROIC Less NNEP Spread (ROIC-NNEP)		 -23.35% 9.38% -15.02% -1.74% 23.22%
Return on Net Nonoperating Assets (RNNOA)		 -1.58% -0.73% 2.85% 0.30% -3.18%
Return on Equity (ROE)		 -11.54% -7.76% -15.43% -20.60% -23.36%
Cash Return on Invested Capital (CROIC)		 0.00% -18.55% -7.10% -19.74% -12.82%
Operating Return on Assets (OROA)		 -11.28% -7.34% -17.43% -21.27% -22.01%
Return on Assets (ROA)		 -8.88% -6.16% -12.71% -17.70% -20.68%
Return on Common Equity (ROCE)		 -11.54% -7.76% -15.43% -20.60% -23.36%
Return on Equity Simple (ROE_SIMPLE)		 -11.54% -6.54% -16.09% -21.57% 0.00%
Net Operating Profit after Tax (NOPAT)		 -25 -19 -49 -52 -48
NOPAT Margin		 -71.73% -31.58% -142.24% -197.61% -258.64%
Net Nonoperating Expense Percent (NNEP)		 13.38% -16.41% -3.26% -19.16% -43.40%
Return On Investment Capital (ROIC_SIMPLE)		 - - -14.38% -16.96% -16.97%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 1.62%
SG&A Expenses to Revenue		 48.77% 42.15% 97.51% 116.48% 156.51%
R&D to Revenue		 112.90% 81.87% 165.45% 208.82% 255.83%
Operating Expenses to Revenue		 202.48% 145.11% 303.19% 382.30% 467.87%
Earnings before Interest and Taxes (EBIT)		 -34 -27 -69 -75 -69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -18 -8.57 -53 -52 -48
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 0.30 2.28 1.49 1.00
Price to Tangible Book Value (P/TBV)		 0.00 1.15 9.55 6.53 4.60
Price to Revenue (P/Rev)		 0.00 1.75 20.99 16.23 14.27
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.15 2.60 1.57 1.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.73 19.13 14.73 12.31
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 278.48 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.07 0.08 0.07 0.07 0.07
Long-Term Debt to Equity		 0.06 0.07 0.07 0.07 0.06
Financial Leverage		 0.07 -0.08 -0.19 -0.17 -0.14
Leverage Ratio		 1.30 1.26 1.21 1.16 1.13
Compound Leverage Factor		 1.30 1.23 1.13 1.12 1.09
Debt to Total Capital		 6.32% 7.59% 6.92% 6.48% 6.15%
Short-Term Debt to Total Capital		 1.01% 1.09% 0.39% 0.17% 0.37%
Long-Term Debt to Total Capital		 5.31% 6.50% 6.53% 6.30% 5.78%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 93.68% 92.41% 93.08% 93.52% 93.84%
Debt to EBITDA		 -0.87 -3.27 -0.44 -0.38 -0.36
Net Debt to EBITDA		 -0.87 7.03 1.19 0.75 0.76
Long-Term Debt to EBITDA		 -0.73 -2.80 -0.41 -0.37 -0.34
Debt to NOPAT		 -0.63 -1.50 -0.48 -0.38 -0.36
Net Debt to NOPAT		 -0.63 3.23 1.31 0.76 0.76
Long-Term Debt to NOPAT		 -0.53 -1.29 -0.45 -0.37 -0.34
Altman Z-Score		 0.00 1.03 6.66 5.86 3.44
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - -
Current Ratio		 1.10 4.80 4.11 4.52 4.02
Quick Ratio		 1.03 4.56 3.93 4.29 3.78
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -49 -19 -49 -31
Operating Cash Flow to CapEx		 -139.36% -20.89% 142.76% -2,115.41% -6,452.21%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -810.29 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -1,391.71 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 0.11 0.16 0.09 0.08 0.06
Accounts Receivable Turnover		 1.64 2.30 2.00 5.79 2.95
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 5.11 4.41 1.79 1.56 1.50
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.15
Days Sales Outstanding (DSO)		 222.02 158.86 182.34 63.04 123.80
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 2,515.25
Cash Conversion Cycle (CCC)		 222.02 158.86 182.34 63.04 -2,391.45
Capital & Investment Metrics		 - - - - -
Invested Capital		 250 281 251 248 231
Invested Capital Turnover		 0.14 0.22 0.13 0.11 0.08
Increase / (Decrease) in Invested Capital		 0.00 31 -30 -2.88 -18
Enterprise Value (EV)		 0.00 43 654 389 230
Market Capitalization		 0.00 104 717 428 266
Book Value per Share		 $8.15 $4.00 $2.71 $2.38 $1.85
Tangible Book Value per Share		 ($0.90) $1.06 $0.65 $0.54 $0.40
Total Capital		 250 369 338 308 285
Total Debt		 16 28 23 20 17
Total Long-Term Debt		 13 24 22 19 16
Net Debt		 16 -60 -64 -40 -37
Capital Expenditures (CapEx)		 4.07 17 1.64 1.88 0.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.50 15 -14 -5.85 -3.89
Debt-free Net Working Capital (DFNWC)		 4.50 103 73 54 50
Net Working Capital (NWC)		 1.97 99 72 53 49
Net Nonoperating Expense (NNE)		 2.12 3.68 2.03 9.88 17
Net Nonoperating Obligations (NNO)		 16 -61 -64 -40 -37
Total Depreciation and Amortization (D&A)		 16 18 16 22 21
Debt-free, Cash-free Net Working Capital to Revenue		 12.96% 24.86% -40.67% -22.18% -20.86%
Debt-free Net Working Capital to Revenue		 12.96% 174.26% 213.93% 203.03% 268.57%
Net Working Capital to Revenue		 5.66% 167.46% 210.12% 201.02% 262.98%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.26) ($0.51) ($0.61) ($0.57)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 85.32M 99.68M 102.37M 113.64M
Adjusted Diluted Earnings per Share		 $0.00 ($0.26) ($0.51) ($0.61) ($0.57)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 85.32M 99.68M 102.37M 113.64M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 115.58M 117.13M 122.13M 144.78M
Normalized Net Operating Profit after Tax (NOPAT)		 -25 -19 -49 -52 -48
Normalized NOPAT Margin		 -71.73% -31.58% -142.24% -197.61% -258.64%
Pre Tax Income Margin		 -98.85% -44.11% -188.39% -270.59% -355.16%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 -4,906.14 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -3,560.90 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -5,487.57 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -4,142.33 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for OmniAb

This table displays calculated financial ratios and metrics derived from OmniAb's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 122,134,941.00 122,335,336.00 122,701,294.00 143,955,400.00 144,782,647.00
DEI Adjusted Shares Outstanding		 - - - - - - 122,134,941.00 122,335,336.00 122,701,294.00 143,955,400.00 144,782,647.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - -0.15 -0.13 -0.13 -0.10 -0.05
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -20.74% -86.36% -77.53% 9.62% -23.83% 124.06% 9.29% -48.82% -46.33% -22.47% 247.30%
EBITDA Growth		 -56.54% -224.54% -302.61% 31.58% 7.12% 50.26% 21.33% -10.92% 9.69% 2.09% 94.86%
EBIT Growth		 -36.21% -334.32% -166.80% 16.12% 2.63% 25.12% 16.45% 0.75% 8.21% 0.67% 58.86%
NOPAT Growth		 -36.26% -331.77% -166.80% 16.15% 2.71% 25.12% 16.45% 0.53% 8.22% 0.72% 58.45%
Net Income Growth		 -24.94% -306.06% -210.84% 7.45% -4.03% 7.01% 4.01% -16.46% -0.93% -8.50% 57.65%
EPS Growth		 -6.67% -255.56% -216.67% 13.33% 0.00% 7.14% 10.53% -15.38% 12.50% 15.38% 64.71%
Operating Cash Flow Growth		 -46.46% -27.69% -161.51% -21.55% -6.13% 57.55% 6.81% 57.76% -48.42% -46.54% 69.04%
Free Cash Flow Firm Growth		 -785.77% 0.00% 51.75% 73.44% 66.80% -155.36% 57.26% 155.74% 130.43% 179.68% 276.90%
Invested Capital Growth		 13.03% -10.59% 0.64% 0.58% 0.22% -1.15% -2.26% -7.19% -6.75% -7.09% -7.49%
Revenue Q/Q Growth		 -21.15% -11.96% -21.17% 100.32% -45.21% 158.96% -61.55% -6.19% -42.55% 274.10% 72.24%
EBITDA Q/Q Growth		 -5.25% -4.73% -6.82% 41.90% -42.88% 43.91% -68.99% 18.08% -16.34% 39.20% 91.13%
EBIT Q/Q Growth		 -4.41% -4.43% -6.35% 27.66% -21.20% 19.68% -18.67% 14.07% -12.08% 13.10% 50.85%
NOPAT Q/Q Growth		 -4.47% -4.39% -6.35% 27.70% -21.21% 19.65% -18.67% 13.93% -11.84% 13.09% 50.34%
Net Income Q/Q Growth		 -6.86% 10.71% -34.92% 28.11% -20.12% 20.19% -39.27% 12.77% -4.09% 14.20% 45.65%
EPS Q/Q Growth		 -6.67% 12.50% -35.71% 31.58% -23.08% 18.75% -30.77% 11.76% 6.67% 21.43% 45.45%
Operating Cash Flow Q/Q Growth		 38.16% -47.16% -86.73% 28.48% 46.00% 41.14% -309.92% 67.58% -89.72% 41.88% 13.39%
Free Cash Flow Firm Q/Q Growth		 10.82% 134.33% -216.97% 25.83% -11.46% 42.75% 9.68% 196.73% -39.16% 49.90% 100.52%
Invested Capital Q/Q Growth		 -1.62% -0.56% 1.48% 1.32% -1.98% -1.92% 0.34% -3.79% -1.52% -2.28% -0.08%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.93% 93.28% 98.70% 99.86% 99.90%
EBITDA Margin		 -297.44% -353.84% -479.51% -139.09% -362.68% -78.55% -345.19% -301.41% -610.32% -99.19% -5.11%
Operating Margin		 -370.91% -439.78% -593.34% -214.15% -473.73% -146.98% -453.64% -416.19% -810.18% -188.23% -54.27%
EBIT Margin		 -370.77% -439.78% -593.34% -214.26% -473.92% -146.98% -453.61% -415.50% -810.54% -188.29% -53.73%
Profit (Net Income) Margin		 -287.35% -291.44% -498.84% -179.03% -392.45% -120.96% -438.13% -407.36% -738.05% -169.28% -53.42%
Tax Burden Percent		 82.65% 70.17% 87.87% 87.78% 85.81% 85.84% 99.42% 100.76% 93.44% 97.48% 106.08%
Interest Burden Percent		 93.77% 94.45% 95.68% 95.19% 96.51% 95.86% 97.15% 97.31% 97.45% 92.23% 93.72%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -70.61% -39.56% -34.43% -12.65% -26.79% -10.88% -33.72% -26.97% -48.95% -10.28% -4.59%
ROIC Less NNEP Spread (ROIC-NNEP)		 -66.41% -40.84% -29.71% -8.74% -22.21% -7.10% -19.67% -11.55% -39.42% -2.01% 3.24%
Return on Net Nonoperating Assets (RNNOA)		 8.75% 7.74% 6.22% 1.58% 4.00% 1.22% 2.44% 1.22% 5.57% 0.28% -0.34%
Return on Equity (ROE)		 -61.87% -31.83% -28.21% -11.07% -22.79% -9.67% -31.29% -25.75% -43.38% -10.00% -4.93%
Cash Return on Invested Capital (CROIC)		 0.00% -7.10% -23.66% -22.45% -22.33% -19.74% -17.39% -12.44% -12.80% -12.82% -9.15%
Operating Return on Assets (OROA)		 -76.22% -37.73% -32.62% -12.53% -26.75% -11.07% -36.83% -30.23% -53.33% -11.22% -5.18%
Return on Assets (ROA)		 -59.07% -25.00% -27.43% -10.47% -22.15% -9.11% -35.58% -29.64% -48.56% -10.09% -5.15%
Return on Common Equity (ROCE)		 -35.08% -31.82% -28.21% -11.07% -22.79% -9.67% -31.29% -25.75% -43.38% -10.00% -4.93%
Return on Equity Simple (ROE_SIMPLE)		 -9.17% 0.00% -21.06% -21.21% -21.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -14 -15 -16 -11 -14 -11 -13 -11 -13 -11 -5.48
NOPAT Margin		 -259.64% -307.84% -415.34% -149.90% -331.61% -102.89% -317.54% -291.33% -567.13% -131.76% -37.99%
Net Nonoperating Expense Percent (NNEP)		 -4.21% 1.27% -4.72% -3.91% -4.58% -3.79% -14.06% -15.41% -9.53% -8.27% -7.82%
Return On Investment Capital (ROIC_SIMPLE)		 - -4.39% - - - -3.61% -4.51% -4.04% -4.30% -3.88% -1.96%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.07% 6.72% 1.30% 0.14% 0.10%
SG&A Expenses to Revenue		 155.40% 163.19% 219.34% 104.61% 169.68% 68.12% 190.54% 197.18% 302.68% 81.65% 45.88%
R&D to Revenue		 253.19% 306.22% 382.82% 183.02% 319.22% 123.16% 303.37% 278.78% 463.56% 166.06% 66.82%
Operating Expenses to Revenue		 470.91% 539.78% 693.34% 314.15% 573.73% 246.98% 553.56% 509.47% 908.89% 288.09% 154.16%
Earnings before Interest and Taxes (EBIT)		 -20 -21 -23 -16 -20 -16 -19 -16 -18 -16 -7.75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -16 -17 -18 -11 -15 -8.49 -14 -12 -14 -8.31 -0.74
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.86 2.28 2.11 1.50 1.71 1.49 1.07 0.81 0.71 1.00 0.87
Price to Tangible Book Value (P/TBV)		 7.37 9.55 9.71 7.04 7.86 6.53 5.36 4.58 3.02 4.60 3.82
Price to Revenue (P/Rev)		 9.32 20.99 30.16 20.31 24.49 16.23 10.96 9.24 9.31 14.27 7.85
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.10 2.60 2.31 1.57 1.82 1.57 1.08 0.79 0.66 1.00 0.85
Enterprise Value to Revenue (EV/Rev)		 8.21 19.13 27.94 18.65 22.59 14.73 10.04 8.26 7.34 12.31 6.74
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 122.72 278.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.08 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.07 0.06
Long-Term Debt to Equity		 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06
Financial Leverage		 -0.13 -0.19 -0.21 -0.18 -0.18 -0.17 -0.12 -0.11 -0.14 -0.14 -0.11
Leverage Ratio		 1.15 1.21 1.19 1.18 1.17 1.16 1.15 1.14 1.13 1.13 1.12
Compound Leverage Factor		 1.08 1.15 1.14 1.13 1.13 1.12 1.11 1.11 1.10 1.04 1.05
Debt to Total Capital		 7.01% 6.92% 6.89% 6.69% 6.60% 6.48% 6.50% 6.78% 6.07% 6.15% 5.99%
Short-Term Debt to Total Capital		 0.50% 0.39% 0.28% 0.10% 0.16% 0.17% 0.12% 0.40% 0.24% 0.37% 0.36%
Long-Term Debt to Total Capital		 6.51% 6.53% 6.62% 6.59% 6.43% 6.30% 6.38% 6.38% 5.83% 5.78% 5.63%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 92.99% 93.08% 93.11% 93.30% 93.40% 93.52% 93.49% 93.22% 93.93% 93.84% 94.01%
Debt to EBITDA		 -1.08 -0.44 -0.33 -0.34 -0.34 -0.38 -0.39 -0.38 -0.37 -0.36 -0.49
Net Debt to EBITDA		 3.19 1.19 0.70 0.58 0.64 0.75 0.51 0.45 0.86 0.76 0.94
Long-Term Debt to EBITDA		 -1.01 -0.41 -0.32 -0.33 -0.33 -0.37 -0.38 -0.36 -0.36 -0.34 -0.46
Debt to NOPAT		 -0.89 -0.48 -0.38 -0.38 -0.37 -0.38 -0.38 -0.39 -0.37 -0.36 -0.41
Net Debt to NOPAT		 2.63 1.31 0.80 0.64 0.69 0.76 0.50 0.46 0.86 0.76 0.80
Long-Term Debt to NOPAT		 -0.83 -0.45 -0.37 -0.37 -0.36 -0.37 -0.38 -0.36 -0.36 -0.34 -0.39
Altman Z-Score		 5.54 7.08 7.26 5.94 7.21 6.45 4.89 3.20 3.05 4.03 3.79
Noncontrolling Interest Sharing Ratio		 43.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.26 4.11 4.38 4.76 4.63 4.52 4.70 3.77 5.00 4.02 4.80
Quick Ratio		 4.10 3.93 4.17 4.53 4.37 4.29 4.39 3.51 4.71 3.78 4.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -43 15 -17 -13 -14 -8.23 -7.44 7.19 4.38 6.56 13
Operating Cash Flow to CapEx		 -1,264.90% -8,524.30% -1,839.31% -1,622.10% -4,327.63% -8,417.39% -7,594.26% -3,118.79% -5,364.29% -63,044.44% -2,942.52%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.21 0.09 0.06 0.06 0.06 0.08 0.08 0.07 0.07 0.06 0.10
Accounts Receivable Turnover		 0.00 2.00 7.18 2.80 4.24 5.79 5.08 4.81 6.40 2.95 3.03
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 1.79 1.13 1.19 1.17 1.56 1.64 1.47 1.42 1.50 2.44
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.14 0.15 0.18
Days Sales Outstanding (DSO)		 0.00 182.34 50.85 130.16 86.13 63.04 71.81 75.94 57.02 123.80 120.56
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 333,914.17 3,333.76 2,568.17 2,515.25 2,077.02
Cash Conversion Cycle (CCC)		 0.00 182.34 50.85 130.16 86.13 63.04 -333,842.36 -3,257.82 -2,511.16 -2,391.45 -1,956.47
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 252 251 255 258 253 248 249 240 236 231 230
Invested Capital Turnover		 0.27 0.13 0.08 0.08 0.08 0.11 0.11 0.09 0.09 0.08 0.12
Increase / (Decrease) in Invested Capital		 29 -30 1.61 1.49 0.55 -2.88 -5.76 -19 -17 -18 -19
Enterprise Value (EV)		 531 654 588 405 461 389 269 190 155 230 195
Market Capitalization		 603 717 635 441 500 428 293 213 196 266 227
Book Value per Share		 $2.79 $2.71 $2.57 $2.50 $2.47 $2.38 $2.24 $2.14 $2.26 $1.85 $1.81
Tangible Book Value per Share		 $0.70 $0.65 $0.56 $0.53 $0.54 $0.54 $0.45 $0.38 $0.53 $0.40 $0.41
Total Capital		 349 338 324 315 312 308 293 281 295 285 279
Total Debt		 24 23 22 21 21 20 19 19 18 17 17
Total Long-Term Debt		 23 22 21 21 20 19 19 18 17 16 16
Net Debt		 -72 -64 -47 -36 -39 -40 -25 -23 -42 -37 -32
Capital Expenditures (CapEx)		 0.49 0.11 0.93 0.75 0.15 0.05 0.21 0.17 0.18 0.01 0.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -13 -14 -8.92 -3.75 -6.66 -5.85 -1.07 -5.51 -5.71 -3.89 3.49
Debt-free Net Working Capital (DFNWC)		 84 73 60 53 53 54 43 36 54 50 53
Net Working Capital (NWC)		 82 72 59 53 52 53 42 35 53 49 52
Net Nonoperating Expense (NNE)		 1.52 -0.79 3.17 2.22 2.54 1.95 5.01 4.52 3.83 3.14 2.23
Net Nonoperating Obligations (NNO)		 -72 -64 -47 -36 -39 -40 -25 -23 -42 -37 -32
Total Depreciation and Amortization (D&A)		 4.02 4.14 4.33 5.72 4.64 7.39 4.50 4.45 4.48 7.46 7.02
Debt-free, Cash-free Net Working Capital to Revenue		 -20.23% -40.67% -42.38% -17.27% -32.65% -22.18% -4.00% -23.94% -27.06% -20.86% 12.06%
Debt-free Net Working Capital to Revenue		 129.15% 213.93% 285.51% 246.27% 258.30% 203.03% 159.00% 156.79% 255.01% 268.57% 181.63%
Net Working Capital to Revenue		 126.44% 210.12% 281.27% 244.76% 255.80% 201.02% 157.68% 151.91% 251.60% 262.98% 178.16%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06)
Adjusted Weighted Average Basic Shares Outstanding		 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M
Adjusted Diluted Earnings per Share		 ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06)
Adjusted Weighted Average Diluted Shares Outstanding		 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 116.24M 117.13M 117.62M 118.16M 121.01M 122.13M 122.34M 122.70M 143.96M 144.78M 144.97M
Normalized Net Operating Profit after Tax (NOPAT)		 -14 -15 -16 -11 -14 -11 -13 -11 -13 -11 -5.48
Normalized NOPAT Margin		 -259.64% -307.84% -415.34% -149.90% -331.61% -102.89% -317.54% -291.33% -567.13% -131.76% -37.99%
Pre Tax Income Margin		 -347.67% -415.35% -567.69% -203.95% -457.36% -140.90% -440.68% -404.31% -789.91% -173.66% -50.36%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

OmniAb’s latest quarter shows a company with a strong cash cushion, but still meaningfully unprofitable and dependent on non-operating income and financing support. In Q1 2026, revenue rose sharply year over year, while cash and investments remained ample. However, operating losses continued, and the balance sheet still carries a large amount of acquired intangible assets and goodwill, which investors should watch closely.

  • Q1 2026 revenue jumped to $14.4 million from $4.2 million in Q1 2025, showing much better top-line momentum.
  • Gross profit was strong at $14.4 million, with cost of revenue just $15,000, indicating an asset-light revenue model.
  • OmniAb ended Q1 2026 with $49.1 million in cash and short-term investments, which provides a solid liquidity cushion.
  • The company has been able to keep total current assets well above total current liabilities, suggesting near-term liquidity is still manageable.
  • Revenue growth accelerated over the past year, with quarterly revenue moving from roughly $3.8 million in Q1 2024 to $14.4 million in Q1 2026.
  • Q1 2026 operating cash flow was still negative at -$4.9 million, so the business has not yet reached cash-flow breakeven.
  • The company’s cash position improved in Q1 2026 mainly because of sales of investments, not operating cash generation.
  • Balance sheet equity remains large at $262.6 million, but much of it reflects prior financing and acquisitions rather than retained profits.
  • OmniAb continues to carry substantial goodwill ($84.0 million) and intangible assets ($119.1 million), which could be a risk if future performance disappoints.
  • The company reported a Q1 2026 net loss of $7.7 million, even after improved revenue.
  • Operating loss in Q1 2026 was -$7.8 million, showing core operations are still not profitable.
  • Research and development plus SG&A and amortization kept total operating expenses high at $22.2 million.
  • Although losses have narrowed from earlier periods, OmniAb has still posted losses in each of the last several quarters, including -$14.2 million in Q4 2025 and -$16.5 million in Q3 2025.
  • The company’s earnings have been volatile, and quarterly cash flow has swung around depending on investment activity and financing inflows.

Longer-term trend: OmniAb has made clear progress on revenue generation, especially compared with 2024, but the company is still in a transition phase. Revenue has improved, and liquidity is healthy, yet the business remains loss-making and has not shown consistent operating leverage. For retail investors, the key question is whether revenue growth can keep scaling faster than expenses.

Bottom line: OmniAb looks financially stable in the near term thanks to its cash and investments, but the stock still depends on continued commercial traction and eventual margin improvement. Until operating losses narrow more materially, the investment case remains higher risk.

07/17/26 07:23 PM ETAI Generated. May Contain Errors.

OmniAb Financials - Frequently Asked Questions

According to the most recent income statement we have on file, OmniAb's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

OmniAb's net income appears to be on an upward trend, with a most recent value of -$64.78 million in 2025, rising from -$27.04 million in 2021. The previous period was -$62.03 million in 2024.

OmniAb's total operating income in 2025 was -$68.97 million, based on the following breakdown:
  • Total Gross Profit: $18.36 million
  • Total Operating Expenses: $87.33 million

Over the last 4 years, OmniAb's total revenue changed from $34.75 million in 2021 to $18.67 million in 2025, a change of -46.3%.

OmniAb's total liabilities were at $33.89 million at the end of 2025, a 10.7% decrease from 2024, and a 51.7% decrease since 2021.

In the past 4 years, OmniAb's cash and equivalents has ranged from $0.00 in 2021 to $33.39 million in 2022, and is currently $25.52 million as of their latest financial filing in 2025.

Over the last 4 years, OmniAb's book value per share changed from 8.15 in 2021 to 1.85 in 2025, a change of -77.2%.


Related Companies

Financial statements for NASDAQ:OABIW last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel